BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dratkiewicz E, Simiczyjew A, Pietraszek-Gremplewicz K, Mazurkiewicz J, Nowak D. Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment. Int J Mol Sci 2019;21:E113. [PMID: 31877948 DOI: 10.3390/ijms21010113] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Cvetanova B, Li MY, Yang CC, Hsiao PW, Yang YC, Feng JH, Shen YC, Nakagawa-Goto K, Lee KH, Shyur LF. Sesquiterpene Lactone Deoxyelephantopin Isolated from Elephantopus scaber and Its Derivative DETD-35 Suppress BRAFV600E Mutant Melanoma Lung Metastasis in Mice. Int J Mol Sci 2021;22:3226. [PMID: 33810045 DOI: 10.3390/ijms22063226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Patel V, Szász I, Koroknai V, Kiss T, Balázs M. Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines. Cancers (Basel) 2021;13:6058. [PMID: 34885166 DOI: 10.3390/cancers13236058] [Reference Citation Analysis]
3 Dent P, Booth L, Poklepovic A, Kirkwood JM. Neratinib kills B-RAF V600E melanoma via ROS-dependent autophagosome formation and death receptor signaling. Pigment Cell Melanoma Res 2021. [PMID: 34482636 DOI: 10.1111/pcmr.13014] [Reference Citation Analysis]
4 Sabbah M, Najem A, Krayem M, Awada A, Journe F, Ghanem GE. RTK Inhibitors in Melanoma: From Bench to Bedside. Cancers (Basel) 2021;13:1685. [PMID: 33918490 DOI: 10.3390/cancers13071685] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Nakagomi N, Sakamoto D, Hirose T, Takagi T, Murase M, Nakagomi T, Yoshimura S, Hirota S. Epithelioid glioblastoma with microglia features: potential for novel therapy. Brain Pathol 2020;30:1119-33. [PMID: 32687679 DOI: 10.1111/bpa.12887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chiu YJ, Yang JS, Tsai FJ, Chiu HY, Juan YN, Lo YH, Chiang JH. Curcumin suppresses cell proliferation and triggers apoptosis in vemurafenib-resistant melanoma cells by downregulating the EGFR signaling pathway. Environ Toxicol 2022. [PMID: 34994998 DOI: 10.1002/tox.23450] [Reference Citation Analysis]
7 Martínez-Campa C, Alonso-González C. Editorial for the Special Issue "New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies". Int J Mol Sci 2020;21:E4081. [PMID: 32521599 DOI: 10.3390/ijms21114081] [Reference Citation Analysis]
8 Shirkavand A, Mohajerani E, Farivar S, Ataie-Fashtami L, Ghazimoradi MH. Monitoring the Response of Skin Melanoma Cell Line (A375) to Treatment with Vemurafenib: A Pilot In Vitro Optical Spectroscopic Study. Photobiomodul Photomed Laser Surg 2021;39:164-77. [PMID: 33595357 DOI: 10.1089/photob.2020.4887] [Reference Citation Analysis]
9 Liu Y, Cai Y, Chang Y. Dual inhibition of RNAi therapeutic miR-26a-5p targeting cMet and immunotherapy against EGFR in endometrial cancer treatment. Ann Transl Med 2021;9:5. [PMID: 33553298 DOI: 10.21037/atm-20-3166] [Reference Citation Analysis]
10 Yeon M, Kim Y, Jung HS, Jeoung D. Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma. Front Cell Dev Biol 2020;8:486. [PMID: 32626712 DOI: 10.3389/fcell.2020.00486] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
11 Shao Z, Pan H, Tu S, Zhang J, Yan S, Shao A. HGF/c-Met Axis: The Advanced Development in Digestive System Cancer. Front Cell Dev Biol 2020;8:801. [PMID: 33195182 DOI: 10.3389/fcell.2020.00801] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Kulbacka J, Chodaczek G, Rossowska J, Szewczyk A, Saczko J, Bazylińska U. Investigating the photodynamic efficacy of chlorin e6 by millisecond pulses in metastatic melanoma cells. Bioelectrochemistry 2021;138:107728. [PMID: 33434787 DOI: 10.1016/j.bioelechem.2020.107728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Shirkavand A, Mohajerani E, Farivar S, Ataie-Fashtami L, Ghazimoradi MH. Quantitative Autofluorescence Imaging of A375 Human Melanoma Cell Samples: A Pilot Study. J Lasers Med Sci 2021;12:e4. [PMID: 34084730 DOI: 10.34172/jlms.2021.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Maxwell MJ, Arnold A, Sweeney H, Chen L, Lih TM, Schnaubelt M, Eberhart CG, Rubens JA, Zhang H, Clark DJ, Raabe EH. Unbiased Proteomic and Phosphoproteomic Analysis Identifies Response Signatures and Novel Susceptibilities After Combined MEK and mTOR Inhibition in BRAFV600E Mutant Glioma. Mol Cell Proteomics 2021;20:100123. [PMID: 34298159 DOI: 10.1016/j.mcpro.2021.100123] [Reference Citation Analysis]